 and
cilostazol þ aspirin vs aspirin. This meta-analysis concluded
that dual antiplatelet therapy was associated with a 31%
relative risk reduction in stroke incidence compared with
monotherapy.136 Finally, consistent with recognition that
plaque instability is greatest early after an ischemic event,
dual antiplatelet therapy appears clinically beneﬁcial in
the early weeks following these events. A meta-analysis of
eight randomized clinical trials including 20,